Ginkgo Bioworks Holdings Total Liabilities

Ginkgo Bioworks Holdings (DNA) currently reports a total liabilities of $590M as of March 2026. That compares with $650M in the prior-year period — down 8.7% year over year. Use the charts on this page to explore Ginkgo Bioworks Holdings's total liabilities history and peer comparisons.

Ginkgo Bioworks Holdings's total liabilities decreased from $650M to $590M — a 8.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ginkgo Bioworks Holdings reported $590M in total liabilities as of March 2026. That compares with $650M in the prior-year period — down 8.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $590M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ginkgo Bioworks Holdings, and consider following DNA for alerts when major investors trade the stock.

Ginkgo Bioworks Holdings is classified in the Healthcare sector. On total liabilities, it currently shows $590M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DNA with unrelated industries.